X
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
Europe
0
Canada
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
0
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761032
https://www.accesswire.com/723138/Ortho-Dermatologics-to-Present-New-Data-at-the-2022-Innovations-in-Dermatology-Conference
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761032
https://www.prnewswire.com/news-releases/ortho-dermatologics-to-present-new-data-at-the-2021-fall-clinical-dermatology-conference-301402874.html
https://leo-pharma.com/media-center/news/leo-pharma-initiates-head-to-head-study-to-evaluate-brodalumab-versus-guselkumab
https://www.prnewswire.com/news-releases/ortho-dermatologics-to-present-new-analyses-at-the-virtual-fall-clinical-dermatology-conference-301159328.html
http://www.pmlive.com/pharma_news/leo_pharma_to_market_astrazenecas_brodalumab_outside_europe_1297760
https://www.fiercepharma.com/pharma/abbvie-s-il-23-hopeful-skyrizi-scores-nod-from-england-s-cost-watchdog?utm_source=internal&utm_medium=rss
https://www.businesswire.com/news/home/20190425005072/en/New-data-show-LEO-Pharma%E2%80%99s-Kyntheum%C2%AE-brodalumab
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761032
https://www.fiercepharma.com/pharma/valeant-dealt-a-major-setback-as-psoriasis-dual-drug-lotion-duobrii-fails-to-impress-fda
Market Place
Share 
